Talzenna
Talzenna ingredients
| Active ingredient | Strength |
|---|---|
| Talazoparib Tosylate | 1 mg/1, .5 mg/1, .1 mg/1, .35 mg/1, .75 mg/1, .25 mg/1 |
What Talzenna is used for
The FDA lists the approved uses on the official label (below). In the EU, talazoparib is approved as Talzenna for:
Treatment with Talzenna should be initiated and supervised by a physician experienced in the use of anticancer medicinal products. Patient selection Breast cancer: Patients should be selected for the treatment of breast cancer with Talzenna based on the presence of deleterious or suspected deleterious germline BRCA mutations determined by an experienced laboratory using a validated test method. Genetic counselling for patients with BRCA mutations should be performed according to local regulations, as applicable. Prostate cancer: There is no requirement for tumour mutation testing for selection of patients with mCRPC for treatment with Talzenna.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Talzenna
- Generic name
- Talazoparib
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Capsule, Capsule, Liquid Filled
- Given
- Oral
- Drug class
- Poly(ADP-Ribose) Polymerase Inhibitor
- FDA approval
- New drug application (NDA) NDA217439
- On the US market since
- 2018
Official information
- MedlinePlus drug information (search for Talazoparib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Talzenna?
Talzenna (Talazoparib) is a cancer medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Talzenna?
Talzenna contains Talazoparib Tosylate (1 mg/1, .5 mg/1, .1 mg/1, .35 mg/1, .75 mg/1, .25 mg/1).
Is Talzenna approved in Europe?
The same active substance is approved in the EU as Talzenna.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA